Intellectual Property
Pharmaceuticals
Pharmaceuticals (1,175) | Intellectual Property (1,175)
- License Agreements (1,148 contracts)
- Trademark Agreements (27)
- 60 DEGREES PHARMACEUTICALS, INC. (5 contracts)
- Accelerated Pharma, Inc. (2)
- ACELRX PHARMACEUTICALS INC (2)
- Acer Therapeutics Inc. (8)
- Aclaris Therapeutics, Inc. (3)
- ACURA PHARMACEUTICALS, INC (4)
- Adamis Pharmaceuticals Corp (12)
- ADIAL PHARMACEUTICALS, INC. (8)
- Aegerion Pharmaceuticals, Inc. (6)
- AEON Biopharma, Inc. (2)
- Aerpio Pharmaceuticals, Inc. (5)
- AGILE THERAPEUTICS INC (2)
- Akers Biosciences, Inc. (1)
- AKESIS PHARMACEUTICALS, INC. (1)
- Akorn (2)
- ALDER BIOPHARMACEUTICALS INC (2)
- Alexza Pharmaceuticals Inc. (4)
- ALIMERA SCIENCES INC (1)
- ALSERES PHARMACEUTICALS INC (9)
- Altus Pharmaceuticals Inc. (4)
- Amag Pharmaceuticals (4)
- Ampio Pharmaceuticals, Inc. (4)
- AMYLIN PHARMACEUTICALS INC (1)
- AN2 Therapeutics, Inc. (2)
- Anacor Pharmaceuticals, Inc. (2)
- Anebulo Pharmaceuticals, Inc. (1)
- Angion Biomedica Corp. (2)
- ANGIOTECH PHARMACEUTICALS INC (8)
- ANI Pharma Inc (10)
- Anthera Pharmaceuticals Inc (1)
- APRICUS BIOSCIENCES, INC. (8)
- Aquestive Therapeutics, Inc. (5)
- ARADIGM CORP (1)
- Aralez Pharmaceuticals Inc. (3)
- ARIAD PHARMACEUTICALS INC (5)
- Arog Pharmaceuticals, Inc. (3)
- ARTELO BIOSCIENCES, INC. (10)
- Artemis Therapeutics, Inc. (2)
- ARVINAS, INC. (6)
- Assertio Holdings, Inc. (1)
- Assertio Therapeutics, Inc (5)
- Astex Pharmaceuticals, Inc (5)
- ATAI Life Sciences B.V. (3)
- Atea Pharmaceuticals, Inc. (1)
- AUXILIUM PHARMACEUTICALS INC (17)
- AVADEL PHARMACEUTICALS PLC (3)
- AVALON PHARMACEUTICALS INC (2)
- AVANIR PHARMACEUTICALS, INC. (1)
- AVENUE THERAPEUTICS, INC. (1)
- Axsome Therapeutics, Inc. (1)
- AYTU BIOSCIENCE, INC (9)
- Bakhu Holdings, Corp. (5)
- BARR PHARMACEUTICALS INC (2)
- Baudax Bio, Inc. (2)
- Bausch Health Companies Inc. (2)
- BENTLEY PHARMACEUTICALS INC (1)
- BIODELIVERY SCIENCES INTERNATIONAL INC (17)
- Biofrontera Inc. (3)
- Biohaven Ltd. (2)
- BioNumerik Pharmaceuticals, Inc. (2)
- BioPharmX Corp (1)
- BODY & MIND INC. (2)
- Boston Therapeutics, Inc. (5)
- BRADLEY PHARMACEUTICALS INC (1)
- Braeburn Pharmaceuticals, Inc. (1)
- CADENCE PHARMACEUTICALS INC (1)
- CALLISTO PHARMACEUTICALS INC (2)
- Canbiola, Inc. (1)
- Cancer Prevention Pharmaceuticals, Inc. (4)
- Cannabics Pharmaceuticals Inc. (3)
- CANNAPOWDER, INC. (1)
- Cantabio Pharmaceuticals Inc. (1)
- Cara Therapeutics, Inc. (7)
- CASSAVA SCIENCES INC (5)
- CELGENE CORP (1)
- Cerecor Inc. (9)
- Charlotte's Web Holdings, Inc. (6)
- CinCor Pharma, Inc. (1)
- Cingulate Inc. (1)
- Citius Pharmaceuticals, Inc. (11)
- Clearside Biomedical, Inc. (12)
- CNS Pharmaceuticals, Inc. (1)
- Cocrystal Pharma, Inc. (6)
- COLLEGIUM PHARMACEUTICAL, INC (1)
- CoLucid Pharmaceuticals, Inc. (2)
- Context Therapeutics Inc. (2)
- ContraVir Pharmaceuticals, Inc. (1)
- CorMedix Inc. (4)
- COSMO VENTURES INC (7)
- CPEX Pharmaceuticals, Inc. (1)
- CUBIST PHARMACEUTICALS INC (10)
- CUMBERLAND PHARMACEUTICALS INC (2)
- Cure Pharmaceutical Holding Corp. (1)
- CymaBay Therapeutics, Inc. (4)
- Dermata Therapeutics, Inc. (2)
- Dova Pharmaceuticals Inc. (1)
- DURECT CORP (23)
- DUSA PHARMACEUTICALS INC (1)
- Egalet Corp (6)
- Elanco Animal Health Inc (4)
- ELITE PHARMACEUTICALS INC (20)
- Elixir Pharmaceuticals, Inc. (4)
- Eloxx Pharmaceuticals, Inc. (17)
- Endo International plc (4)
- Endo Pharmaceuticals Solutions Inc. (10)
- EPIX Pharmaceuticals, Inc. (5)
- Eton Pharmaceuticals, Inc. (3)
- Evofem Biosciences, Inc. (2)
- Evolus, Inc. (4)
- Exactus, Inc. (1)
- EYEGATE PHARMACEUTICALS INC (6)
- EYENOVIA, INC. (6)
- EyePoint Pharmaceuticals, Inc. (4)
- EYETECH PHARMACEUTICALS INC (3)
- Fulcrum Therapeutics, Inc. (2)
- GRAYBUG VISION, INC. (1)
- GUILFORD PHARMACEUTICALS INC (4)
- Harmony Biosciences Holdings, Inc. (1)
- HARROW HEALTH, INC. (8)
- Horizon Pharma plc (20)
- Hoth Therapeutics, Inc. (7)
- IDENIX PHARMACEUTICALS INC (7)
- Ikena Oncology, Inc. (2)
- IMAGING3 INC (2)
- IMARA Inc. (5)
- INNOVATE BIOPHARMACEUTICALS, INC. (8)
- Innoviva, Inc. (1)
- Innovive Pharmaceuticals, Inc. (3)
- INSPIRE PHARMACEUTICALS INC (8)
- IntelGenx Technologies Corp. (1)
- Intra-Cellular Therapies, Inc. (4)
- ISTA PHARMACEUTICALS INC (2)
- Item 9 Labs Corp. (1)
- Iterum Therapeutics plc (1)
- Jaguar Health, Inc. (8)
- Jazz Pharmaceuticals plc (16)
- Johnson & Johnson (1)
- Journey Medical Corp (3)
- JUNIPER PHARMACEUTICALS INC (13)
- Kala Pharmaceuticals, Inc. (5)
- Kannalife Inc (2)
- KING PHARMACEUTICALS INC (5)
- KOS PHARMACEUTICALS INC (3)
- Lannett Company, Inc. (3)
- Level Brands, Inc. (5)
- Lexaria Bioscience Corp. (15)
- Lipocine Inc. (2)
- Liquidia Corp (1)
- Longboard Pharmaceuticals, Inc. (3)
- Luckwel Pharmaceuticals Inc. (3)
- Lumena Pharmaceuticals, Inc. (3)
- MAP Pharmaceuticals, Inc. (4)
- MARINUS PHARMACEUTICALS INC (2)
- MAXIM PHARMACEUTICALS INC (2)
- Medicine Man Technologies, Inc. (3)
- MEMORY PHARMACEUTICALS CORP (1)
- Menlo Therapeutics Inc. (4)
- MiddleBrook Pharmaceuticals, Inc. (1)
- MJ Holdings, Inc. (2)
- Molecular Insight Pharmaceuticals, Inc. (13)
- MYnd Analytics, Inc. (1)
- Nabriva Therapeutics plc (3)
- NEKTAR THERAPEUTICS (4)
- Neos Therapeutics, Inc. (2)
- Neuralstem, Inc. (3)
- NEW RIVER PHARMACEUTICALS INC (1)
- NewBridge Global Ventures, Inc. (3)
- NEXIEN BIOPHARMA, INC. (2)
- Notis Global, Inc. (1)
- NovaBay Pharmaceuticals, Inc. (1)
- Novan, Inc. (15)
- NOVEN PHARMACEUTICALS INC (1)
- NPS PHARMACEUTICALS INC (16)
- OCULAR THERAPEUTIX, INC (4)
- Odonate Therapeutics, Inc. (1)
- OMEROS CORP (7)
- Omthera Pharmaceuticals, Inc. (2)
- OncoMed Pharmaceuticals Inc (13)
- Onconova Therapeutics, Inc. (3)
- ONYX PHARMACEUTICALS INC (1)
- OPIANT PHARMACEUTICALS, INC. (11)
- OPTIMER PHARMACEUTICALS INC (2)
- OptiNose, Inc. (3)
- ORAMED PHARMACEUTICALS INC. (1)
- Organon & Co. (1)
- OSCIENT PHARMACEUTICALS CORP (8)
- OSI PHARMACEUTICALS INC (6)
- Osmotica Pharmaceuticals plc (1)
- OTONOMY, INC. (2)
- PANACOS PHARMACEUTICALS, INC. (3)
- Paratek Pharmaceuticals, Inc. (20)
- PaxMedica, Inc. (4)
- PEAK PHARMACEUTICALS, INC. (1)
- Petros Pharmaceuticals, Inc. (3)
- Phathom Pharmaceuticals, Inc. (3)
- Phoenix Life Sciences International Limited. (1)
- Pivot Pharmaceuticals Inc. (2)
- PLx Pharma Inc. (7)
- PONIARD PHARMACEUTICALS, INC. (2)
- PREDIX PHARMACEUTICALS HOLDINGS INC (2)
- Prestige Brands Holdings Inc (1)
- PRESTWICK PHARMACEUTICALS INC (2)
- Processa Pharmaceuticals, Inc. (10)
- ProPhase Labs, Inc. (2)
- PROTEO INC (2)
- Provention Bio, Inc. (7)
- Pulmatrix, Inc. (5)
- QUARK PHARMACEUTICALS INC (14)
- QUATRX PHARMACEUTICALS CO (6)
- QUESTCOR PHARMACEUTICALS INC (1)
- Ra Pharmaceuticals, Inc. (2)
- RADIENT PHARMACEUTICALS Corp (6)
- Rain Therapeutics Inc. (3)
- Rani Therapeutics Holdings, Inc. (3)
- REATA PHARMACEUTICALS INC (22)
- Recro Pharma, Inc. (8)
- Reliant Pharmaceuticals, Inc. (10)
- RELMADA THERAPEUTICS, INC. (5)
- RespireRx Pharmaceuticals Inc. (7)
- resTORbio, Inc. (10)
- Revance Therapeutics, Inc. (7)
- Rib-X Pharmaceuticals, Inc. (6)
- ROCK CREEK PHARMACEUTICALS, INC. (1)
- Roivant Sciences Ltd. (2)
- SALIX PHARMACEUTICALS LTD (15)
- SAMARITAN PHARMACEUTICALS INC (1)
- SAVIENT PHARMACEUTICALS INC (1)
- SCICLONE PHARMACEUTICALS INC (1)
- Scopus BioPharma Inc. (7)
- scPharmaceuticals Inc. (1)
- SCYNEXIS INC (10)
- SenesTech, Inc. (1)
- SHAMAN PHARMACEUTICALS INC (1)
- Somanta Pharmaceuticals Inc. (1)
- Sonoma Pharmaceuticals, Inc. (8)
- Strongbridge Biopharma plc (1)
- Sucampo Pharmaceuticals, Inc. (4)
- Supernus Pharmaceuticals, Inc. (8)
- Synovics Pharmaceuticals (1)
- Target Group Inc. (1)
- Tarsus Pharmaceuticals, Inc. (5)
- TAURIGA SCIENCES, INC. (4)
- Terns Pharmaceuticals, Inc. (3)
- TETRALOGIC PHARMACEUTICALS CORP (2)
- TETRAPHASE PHARMACEUTICALS INC (2)
- Textmunication Holdings, Inc. (1)
- TFF Pharmaceuticals, Inc. (3)
- The Medicines Company (1)
- TherapeuticsMD, Inc. (6)
- Theravance Biopharma, Inc. (3)
- Theseus Pharmaceuticals, Inc. (1)
- Tilray, Inc. (3)
- TITAN PHARMACEUTICALS INC (4)
- Trevi Therapeutics, Inc. (4)
- Tribute Pharmaceuticals Canada Inc. (3)
- United Cannabis Corp (1)
- Upjohn Inc (1)
- Urigen Pharmaceuticals, Inc. (5)
- Urovant Sciences Ltd. (3)
- Valera Pharmaceuticals Inc (4)
- Vallon Pharmaceuticals, Inc. (1)
- Verrica Pharmaceuticals Inc. (1)
- VIA Pharmaceuticals, Inc. (6)
- Virpax Pharmaceuticals, Inc. (6)
- Vitality Biopharma, Inc. (3)
- VIVUS INC (7)
- Wave Life Sciences Ltd. (3)
- WEED, INC. (1)
- Zoetis (7)
- ZOGENIX, INC. (5)
- Zomedica Pharmaceuticals Corp. (4)
- Patent and Technology License Agreement, dated May 14, 2014, between Novel Anti-Infective Technologies, LLC and Leonard-Meron Biosciences, Inc (Citius Pharmaceuticals, Inc., Filed With SEC on May 12, 2023)
- AnnJi License Agreement by and between the Company and AnnJi Pharmaceutical Co. Ltd., dated February 28, 2023 (AVENUE THERAPEUTICS, INC., Filed With SEC on May 12, 2023)
- Development and License (Biohaven Ltd., Filed With SEC on May 12, 2023)
- Amendment to Development and License Agreement dated March 21 (Biohaven Ltd., Filed With SEC on May 12, 2023)
- Second Letter Amendment to License Agreement dated (Revance Therapeutics, Inc., Filed With SEC on May 9, 2023)
- First Addendum to the License and Service Agreement dated April 21, 2009, by and between Revance Therapeutics, Inc. and List Biological Laboratories, Inc (Revance Therapeutics, Inc., Filed With SEC on May 9, 2023)
- License and Service Agreement dated February 8, 2007, by and between Revance Therapeutics, Inc. and List Biological Laboratories, Inc (Revance Therapeutics, Inc., Filed With SEC on May 9, 2023)
- Research License Agreement, dated as of March 31, 2023, by and between Liquidia Technologies, Inc. and Glaxo Group Limited (Liquidia Corp, Filed With SEC on May 8, 2023)
- Trademark Phase-Out License Agreement, dated as of April 3, 2023, by and between Johnson & Johnson and Johnson & Johnson Consumer Inc (Johnson & Johnson, Filed With SEC on May 8, 2023)
- Exclusive License Agreement dated as of September 15, 2016, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- Exclusive License Agreement dated as of May 30, 2014, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- Amendment No. 1 to the License Agreement between TherapeuticsMD, Inc. and Mayne Pharma LLC, dated as of December 30, 2022 (TherapeuticsMD, Inc., Filed With SEC on April 7, 2023)
- Exclusive License Agreement dated as of May 30, 2014, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
- Exclusive License Agreement dated as of May 30, 2014, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
- Exclusive License Agreement dated as of September 15, 2016, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
- License and Assignment Agreement, dated as of January 30, 2008, between the Company and ND Partners LLC (CorMedix Inc., Filed With SEC on March 30, 2023)
- First Amendment, dated January 12, 2017 to the License Agreement, dated January 12, 2017, by and between Novan, Inc. and Sato Pharmaceutical Co. Ltd (Novan, Inc., Filed With SEC on March 30, 2023)
- License Agreement, dated January 12, 2017, by and between Novan, Inc. and Sato Pharmaceutical Co. Ltd (Novan, Inc., Filed With SEC on March 30, 2023)
- License Agreement, dated May 10, 2022, by and between Indus LF LLC and Medicine Man Technologies, Inc (Medicine Man Technologies, Inc., Filed With SEC on March 29, 2023)
- Brand License and Option Agreement, dated as of January 5, 2023 by and between JMS Brands LLC, and Charlottes Web, Inc (Charlotte's Web Holdings, Inc., Filed With SEC on March 23, 2023)
- License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022 (Zomedica Pharmaceuticals Corp., Filed With SEC on March 15, 2023)
- Technology License Agreement, effective August 28, 2020 between Omeros Corporation and Xencor, Inc (OMEROS CORP, Filed With SEC on March 13, 2023)
- License and Supply Agreement, dated as of September 30, 2013, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Evolus, Inc., Filed With SEC on March 8, 2023)
- Extension and Fifth Amending Agreement to Name and Likeness and License Agreement, effective as of February 17, 2023, by and between Leeland & Sig LLC d/b/a Stanley Brothers Brand... (Charlotte's Web Holdings, Inc., Filed With SEC on February 22, 2023)
- Development and Manufacturing License Agreement by and among Qorvo Biotechnologies, LLC, Zomedica Inc. and Zomedica Corp (Zomedica Pharmaceuticals Corp., Filed With SEC on January 24, 2023)
- Second Amendment to Respirerx -University Of Illinois Exclusive License Agreement (RespireRx Pharmaceuticals Inc., Filed With SEC on January 23, 2023)
- Amendment No. 2 dated December 27, 2022, to the License Agreement originally dated January 16, 2018, as heretofore amended, between Relmada Therapeutics, Inc., and Dr. Charles E.... (RELMADA THERAPEUTICS, INC., Filed With SEC on December 28, 2022)
- License Agreement, effective December 21, 2022, by and between Sato Pharmaceutical Co., Ltd., and EPI Health, LLC (Novan, Inc., Filed With SEC on December 21, 2022)
- License Agreement between Titan Pharmaceuticals, Inc. and Ocular Therapeutix, Inc., dated as of December 6, 2022 (TITAN PHARMACEUTICALS INC, Filed With SEC on December 12, 2022)
- License Agreement by and between TherapeuticsMD, Inc. and Mayne Pharma LLC, dated December 4, 2022 (TherapeuticsMD, Inc., Filed With SEC on December 5, 2022)
- PPARd License Agreement, dated June 20, 2006, by and between Metabolex, Inc. and Janssen Pharmaceutica NV (CymaBay Therapeutics, Inc., Filed With SEC on November 14, 2022)
- License Agreement, dated November (Context Therapeutics Inc., Filed With SEC on November 9, 2022)
- License Agreement, dated July 29, 2022, by and between Apollo AP43 Limited and Avalo Therapeutics, Inc (Cerecor Inc., Filed With SEC on November 7, 2022)
- Manufacturing and Sales License Agreement, effective November 1, 2022 by and among Aphria, Inc. and Charlottes Web, Inc (Charlotte's Web Holdings, Inc., Filed With SEC on November 4, 2022)
- First Amendment to License Agreement by and between the Company and Innocoll Pharmaceuticals Limited dated September 19, 2022 (DURECT CORP, Filed With SEC on November 3, 2022)
- Second Amendment to License Agreement by and between the Registrant and Arena Pharmaceuticals, Inc., dated September 13, 2022 (Longboard Pharmaceuticals, Inc., Filed With SEC on November 3, 2022)
- License and Commercialization Agreement dated July 31, 2022, by and between Bioprojet Societe Civile de Recherche and Harmony Biosciences, LLC (Harmony Biosciences Holdings, Inc., Filed With SEC on November 1, 2022)
- Amended and Restated License and Services Agreement, dated October 11, 2022, by and among Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD and Tao Wang (Jaguar Health, Inc., Filed With SEC on October 14, 2022)
- Extension and Fourth Amending Agreement to Name and Likeness and License Agreement, effective as of September 30, 2022, by and between Leeland & Sig LLC d/b/a Stanley Brothers... (Charlotte's Web Holdings, Inc., Filed With SEC on October 4, 2022)
- Extension and Third Amending Agreement to Name and Likeness and License Agreement, effective as of August 31, 2022, by and between Leeland & Sig LLC d/b/a Stanley Brothers Brand... (Charlotte's Web Holdings, Inc., Filed With SEC on September 2, 2022)